Co. has equivalent to 40% of its MC in cash. IN CASH! And with no debt apparently! Yet, no one wants to touch it.So...what’s missing here? Doesn’t add up.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%